Basilea Pharmaceutica AG Allschwil Eulerpool News

Basilea Pharmaceutica AG Allschwil Eulerpool News

Basilea Pharmaceutica AG Allschwil Stock News

Basilea Pharmaceutica AG Allschwil is being monitored by journalists and investors worldwide. We gather the latest Basilea Pharmaceutica AG Allschwil news here.

• May 21 ·

  Yahoo
  Basilea Pharmaceutica (BPMUF) Is a Great Choice for 'Trend' Investors, Here's Why
• May 16 ·

  Yahoo
  Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea
• May 3 ·

  Yahoo
  Basilea reports presentation of new data for ceftobiprole (Zevtera®) at ESCMID Global 2024
• April 24 ·

  Yahoo
  Basilea shareholders approve all proposals of the board of directors at the annual general meeting
• April 9 ·

  Yahoo
  Basilea awarded CARB-X grant to develop recently acquired novel class of antibiotics
• April 4 ·

  Yahoo
  Basilea announces US FDA approval of antibiotic ZEVTERA® (ceftobiprole medocaril) for three indications
• April 4 ·

  Thefly.com
  Basilea price target raised to CHF 94 from CHF 85 at H.C. Wainwright
• March 11 ·

  Yahoo
  Continued strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea
• February 13 ·

  Seeking Alpha
  Basilea Pharmaceutica AG GAAP EPS of CHF0.86, revenue of CHF157.6M
• February 13 ·

  Yahoo
  Basilea reports strong 2023 full-year results with profitability significantly above guidance, whilst substantially expanding the R&D portfolio